Homeobox (HOX) genes are conserved transcription factors which determine the anteriorposterior body axis patterning. HOXD8 is a member of HOX genes deregulated in several tumors such as lung carcinoma, neuroblastoma, glioma and colorectal cancer (CRC) in a context-dependent manner. In CRC, HOXD8 is downregulated in cancer tissues and metastatic foci as compared to normal tissues. Whether HOXD8 acts as a tumor suppressor of malignant progression and metastasis is still unclear. Also, the underlying mechanism of its function including the downstream targets is totally unknown. Here, we clarified the lower expression of HOXD8 in clinical colorectal cancer vs. normal colon tissues. Also, we showed that stable expression of HOXD8 in colorectal cancer cells significantly reduced the cell proliferation, anchorage-independent growth and invasion. Further, using The Cancer Genome Atlas (TCGA), we identified the genes associated with HOXD8 in order to demonstrate its function as a suppressor or a promoter of colorectal carcinoma. Among inversely related genes, apoptotic inhibitors like STK38 kinase and MYC were shown to be negatively associated with HOXD8.
1.

Introduction
The homeobox (HOX) genes are developmental regulatory genes which give cells positional information in embryogenesis [1] . There is a common sequence element of 180 bp encoding for highly conserved 60-amino-acid homeodomain called the homeobox. This binding ability of HOX genes to DNA is conferred by the homeodomain to act as transcription factors (TF) [2] . HOXA, HOXB, HOXC and HOXD, found on separate chromosomes are forming the four gene clusters of 39 HOX genes in mammals [3] . In a highly coordinated manner, the HOX genes are expressed spatio-temporally during emryogenesis to build up regional identities along the anteriorposterior body axis [4] . The role of HOX genes to regulate the differentiation or maturation in organs and tissues is not exclusive to the embryo. It has recently become apparent that the patterns of expression of HOX genes are organ-or tissue characteristic not only in the embryo but also in the adult or post-natal body [5] . Furthermore, aberrant expression of particular HOX genes has been reported in several types of carcinomas suggesting that HOX genes are involved in oncogenesis and malignant progression [6] . For instance, expression of 39 HOX genes was deregulated in lung, breast, oral and esophageal cancers and melanoma [7] [8] [9] [10] [11] . Other reports also showed differences in expression patterns of HOX genes in cancers of kidney, colon, prostate, and uterus [12] [13] [14] [15] .
Nine genes (HOXD1, HOXD3, HOXD4, and HOXD8-13) constitute the HOXD cluster and are positioned sequentially from 3' to 5', with HOXD1 at the 3' end and HOXD13 at the 5' end.
Among HOXD cluster, induction of HOXD8, HOXD9, HOXD10 or HOXD12 induces growth arrest and neuronal differentiation with downregulation of cell cycle-promoting genes and upregulation of differentiation genes [16] . Nevertheless, other HOXD genes like HOXD1, HOXD3, HOXD4, HOXD11 and HOXD13 have no or partial effects on neuroblastoma cell proliferation or differentiation [16] . These findings highlight the distinct functions of HOXD genes in the induction of cancer cell differentiation.
In colorectal cancer (CRC), HOXD8 expression was downregulated in clinical cancer tissues especially in metastatic foci as compared to primary tissues [1] . Also, HOXD8 is among the downstream restricted targets of miR-196a which has a potential oncogenic function in colorectal cancer. Depletion of HOXD8 mRNA levels by miR-196a in colorectal cancer results in inhibition of differentiation and promotion of oncogenic features [17] . In this sense, lowered expression of HOXD8 in colorectal cancer tissues fascinated us to understand the role of HOXD8 in CRC and explain whether HOXD8 may act as a tumor suppressor of malignant progression and metastasis.
In the current study, we demonstrated that HOXD8 expression suppresses colorectal cancer cell proliferation, colony forming capacity and invasion. TCGA analysis showed that HOXD8 is negatively associated with STK38 and MYC which have a negative impact on apoptotic pathways rendering infinite cancer cell growth. Stable expression of HOXD8 downregulated the expression of MYC mRNA and upregulated the apoptotic marker proteins. Our results uncover for the first time, the relationship between HOXD8, STK38 and MYC in apoptosis of cancer cells.
Further studies are warranted to elucidate the mechanistic insights of this association and to uncover more downstream targets of HOXD8 in CRC and other types of cancer.
2.
Materials and Methods
Culture cells and antibodies
Colorectal cancer cells, HCT116, DLD-1 and HT29 cells, were obtained from American Type
Culture Collection (ATCC) and cultured in DMEM (for HCT116 and HT29) or RPMI (for DLD-1)
supplemented with 10% fetal bovine serum (FBS) (EQUITEC, Hen-dra, Australia). We authenticated the cancer cells by short tandem repeat analysis using gene print®10 system (Promega,Madison, WI). The antibodies used were purchased from the following manufacturers:
anti-E-cadherin antibody, BD Biosciences (San Jose, CA); anti-β-actin antibody, Sigma-Aldrich, St. Louis,MO, USA; anti-GFP antibody, Neuro Mab (Davis,CA); anti-palladin, as previously produced [18, 19] ; anti-cleaved caspase-6 (Asp162), anti-cleaved caspase-7 (Asp198), anti-cleaved PARP (Asp214), anti-phospho-ERK1/2 and anti-phospho-AKT (Ser473) antibodies, cell signaling technology ® , Danvers, MA, USA.
Patients and ethical statement
Normal and colorectal cancer patients who went through surgery at Nagoya University graduate school of Medicine hospital were participating in this study. For the detection of HOXD8 mRNA expression levels in normal vs. colorectal cancer specimens (stages II-IV collected from male and female patients (Age 30-60 yr).), qRT-PCR analysis was performed.
Written informed consents were provided from the participating patients and the study plan was approved by the institutional review board of the university as conformed to the standards set by the Declaration of Helsinki.
2.3.
qRT-PCR (Quantitative Real-Time PCR)
Endogenous mRNA from normal colon and colorectal cancer samples was extracted using the RNeasy mini kit (Qiagen, Venlo, Netherlands), and then the corresponding cDNAs were synthesized using primescript Reverse Transcriptase (TAKARA, Tokyo, Japan). The normal colon and colorectal cancer tissues were obtained from patients who underwent surgery at the Nagoya University Hospital. The real time PCR was performed using the SYBR Premix Ex Taq TM II (TAKARTA), and the Thermal Cycler Dice TM Real Time System TP800 (TAKARA) was utilized for the analysis and quantification of the gene expression. The relative mRNA level of each gene was normalized to GAPDH. The sequences of primers used to amplify each gene were 5´-AGGTGGAGGAGTGGGTGTCGCTGTT-3´ and 5´-CCGGGAAACTGTGGCGTGATGG-3´
(GAPDH), 5´-GTTTTGAACCGCCCTTGTAA-3´ and 5´-GTGAGGCTATCGCTTTCCTG-3´
(HOXD8), and 5'-CATCAGCACAACTACGCAGC-3' and 5'-GCTGGTGCATTTTCGGTTGT-3' (MYC).
Analysis of Oncomine data
To determine the expression pattern of HOXD8 in colorectal cancer, the datasets in Oncomine, a cancer microarray database (https://www.oncomine.org), were utilized. In brief, HOXD8 gene was queried in the database and the results were filtered by selecting colorectal cancer and Colon Cancer vs. Normal Analysis. The data was displayed by using Column chart. P-values for each group were calculated using student t-test. Other details of standardized normalization techniques and statistical calculations can be found on the Oncomine.
cDNA constructs
Complementary DNA (cDNA) for the human gene; HOXD8 was amplified by Polymerase Chain Reaction (PCR) from a cDNA library of HeLa cells. A cDNA library simply contains sequences that are complementary to mRNAs transcribed from the human genome. The cDNA was then cloned into the pQCXIP vector (TAKATA, Tokyo, Japan) with an N-terminal green fluorescence protein (GFP) tag as described previously [20] . Hence, GFP or GFP HOXD8 clones were ready for retroviral infection into the cancer cells. St. Louis, MO, USA) for three constitutive days as described previously [21] .
Western blot analysis
Western blotting analysis was conducted as described previously [22] . the ECL system (Nacalai tesque, Kyoto, Japan). The signals' intensities were detected using Light Capture II equipped with CS analyzer (ATTO Corp., Tokyo, Japan).
MTT cell proliferation assay
The MTT cell proliferation assay is a colorimetric assay for assessing the proliferation rate of the cells. The assay depends on the activity of NADPH-dependent cellular oxidoreductase enzymes which reflect the number of viable cells. These enzymes are able to reduce the tetrazolium dye MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to its insoluble form, formazan, forming a purple color indicative of the number of cells present. The cells were infected with retrovirus for constitutive expression of GFP or GFP HOXD8 and cultured in 96-well plates. Then, after establishment of the stable cell lines, MTT assay was conducted from day 0, and the number of the cells at the indicated time points were estimated using the Cell Count Kit-8 (Dojindo, Tokyo, Japan) as described previously [23] .
Colony formation assay
The colony forming capacity or anchorage-independent growth assay was performed as described previously [24] . Briefly, HCT116, DLD-1, HT29 cells (1 x 10 4 ) were cultured with 0.36% agar in 10% FBS DMEM and overlaid onto a 0.72% agarose layer in 6-well plates. After 2 weeks of incubation at 37°C, growing colonies in five randomly selected fields were counted. Three independent experiments were performed to assure the validity of the results and the data are shown as the mean ± SE.
Cancer cell invasion assay
To assess the cancer cell invasiveness using Boyden chambers, a filter (8-µm pore size, 6.5-mm membrane diameter) was pre-coated with matrigel overnight. Then, 2 x 10 5 HCT116 cells or 2 x 10 4 DLD-1 cells were seeded onto the upper surface of the chamber with DMEM and 0.1% BSA (starvation) while the lower chamber was filled with DMEM and 10% FBS (chemo-attractant).
After 24 h incubation at 37°C, the cells were fixed with 70% methanol and stained with 0.5% crystal violet. The cells which invaded the lower surface of the filters were counted in 5 randomly selected fields as described previously [25] . Three independent experiments were performed.
Homology modeling by the server SWISS-MODEL
The server searches for the template with Blast and HHBlits against the SWISS-MODEL template library and the templates with the highest quality have been chosen for model building. Models are built based on the target (HOXD8)-template alignment using ProMod3.
Coordinates conserved between the target and the template are copied from the template to the model. The geometry of the resulting model is regularized by using a force field. Also, homooligomeric structure of the target protein (HOXD8) is predicted based on the analysis of pairwise interfaces of the identified template structures. More details of the model building, model quality estimation, ligand modeling, oligomeric state conservation can be found on the server Swiss-model.
TUNEL assay
The Terminal DNA transferase-mediated dUTP nick end labeling (TUNEL) assay was performed to determine in situ apoptotic DNA breaks by using the detection kit (Roche, Basel, Switzerland) according to the manufacturer's protocol. HCT116, DLD-1 and HT29 cells expressing FLAG or FLAG HOXD8 were established by retroviral infection. Cells attached to glass slides in culture dishes were subjected to the assay, imaged with fluorescence microscopy, and the percentage of TUNEL-positive cells was evaluated.
Statistical analysis
All data presented are as the mean ± Standard Error (SE). Statistical analysis for cancer cell proliferation, and colony forming capacity was performed by unpaired t-test using Microsoft
Office Excel 2013. P values of <0.05 were considered statistically significant.
Results
HOXD8 mRNA is reduced in clinical colon cancer samples and HOXD8 expression reduces cancer cell proliferation in vitro
In order to unravel the function of the homeobox D8 in colorectal cancer, we first examined HOXD8 mRNA levels in human normal colon and colorectal cancer specimens by qRT-PCR analysis. The analysis revealed a significant reduction in mRNA levels of HOXD8 in 18 human colorectal cancer tissues with 9 samples showing more than 5-fold decreases in HOXD8 mRNA compared with the normal controls (Fig. 1A) . In parallel, we analyzed seven independent datasets from Oncomine database. The results showed that HOXD8 mRNA was differentially expressed in colon carcinoma in comparison to normal lung tissues. Among 40 samples, HOXD8 expression in Skrzypczak Colorectal 2 dataset showed around 8-fold reduction in colon cancer as compared to the normal colon (Fig. 1B) . These observations suggested that HOXD8 expression was reduced in colon cancer tissues. We next examined the expression level of HOXD8 in various colorectal cancer cell lines. qRT-PCR analysis showed that HOXD8 was expressed relatively high in SW620 and SW1080 cancer cells while expressed relatively low in HT29, DLD-1 and HCT116 cells (Fig. 1C) . Fig. 1A ).
The capability of cancer cells to exhibit anchorage-independent cell growth (colony formation capacity in semisolid media), has been considered to be a fundamental process in cancer biology.
This is because it has been associated with cancer cell aggressiveness in vivo such as tumorigenic and metastatic potentials, and also used as a marker for in vitro cancer transformation. To explore whether HOXD8 expression inhibits the anchorage-independent growth of colorectal cancer cells, HOXD8-expressing cells were cultured in soft agar. After two weeks, the number of colonies and average colony size were determined. The results showed a significant suppression of the growth of HOXD8-expressng cells in the absence of cell adhesion to the extracellular matrix ( Fig. 2A, 2B and 2C ). These results show that HOXD8 has a suppressive effect on cancer cell proliferation and colony forming capacity.
Exogenous expression of HOXD8 inhibits cancer cell invasion
Cancer cell invasiveness and metastatic ability is a multistep process that comprises cell adherence modulation, extracellular matrix degradation, migration and proliferation at a secondary site; finally, tumor cells must also stimulate angiogenesis to attain increased growth requirements. Therefore, it is very important to measure the invasive ability of cancer cells to assess the tumor suppression character of certain genes. The Matrigel 'chemoinvasion' assay is a useful tool for this purpose and for screening of anti-invasive agents. One major simplification of this assay is the use of a reconstituted membrane 'Matrigel', which when applied in the Boyden chamber, cancer cell invasive potential can be rapidly quantified. This in vitro invasion assay was found to correspond to metastatic potential in vivo [26] .
To evaluate cell invasion in HOXD8 expressing cells, we first observed the morphology of several colorectal cancer cells upon constitutive expression of HOXD8. As shown in Fig. 3A [27] and HHBlits [28] [29] [30] [31] for evolutionary similar structures which match the target sequence of HOXD8. The template protein was found to be 2r5z.1.C which is a homeotic protein Sex combs reduced with 65.79 sequence identity and 0.51 sequence similarity ( Fig. 4A and 4B ). The HOXD8 has N-terminus residues spanning around 290 amino acids that through our analysis, the software predicted formation of three helices after comparing 181-256 amino acids residues with the template protein ( Fig. 4C and 4D) . But, the remaining residues contain abnormally abundant poly-A and poly-P that hindered the formation of any stable ternary structure.
HOXD8 expression downregulates palladin and upregulates E-cadherin
Due to the observed role of HOXD8 to suppress cancer cell invasiveness and modulate the fibroblast like cells to spherical shape, we checked the expression of palladin and E-cadherin in HOXD8 expressing cells. Palladin (PALLD) is an actin-associated protein with 9 isoforms as showed by the Universal Protein Database. Several reports including our recent study [19] have revealed that palladin is associated with malignant characteristics of multiple malignancies including colorectal cancer. Here, we examined palladin expression in HOXD8 expressing cells.
We generated either GFP or GFP HOXD8 expressing HCT116 and DLD-1 cells by retrovirus have been identified with transcription factor activity and sequence-specific DNA binding according to gene ontology (GO) annotations (Table 1) . These structural homologs are sequencespecific transcription factors involved in developmental regulatory system to provide cells with specific positional identities on the anterior-posterior axis.
On the other hand, among 6 inversely correlated genes with HOXD8, STK38 (Serine/Threonine Kinase 38) and the well-known oncoprotein MYC have been identified by TCGA analysis (Table   2 ). Moreover, the dataset from TCGA database was analyzed to examine the correlation between HOXD8 and, STK38 and MYC at mRNA level in clinical colorectal cancer specimens by the cBioPortal platform. As shown in Fig. 6A and 6B, the correlation analysis in TCGA database (Fig. 6C) . To confirm the negative association between HOXD8 and MYC, we used qRT-PCR analysis to check the expression of MYC mRNA levels in either GFP or GFP HOXD8. As shown in Fig. 6D , exogenous expression of HOXD8 in HCT116, DLD-1 and HT29 cells downregulated MYC mRNA levels as compared to GFP only cells.
Expression of HOXD8 augments apoptosis of colorectal cancer cells
Serine-threonine kinase 38, STK38/NDR1 has been shown to be a potential "druggable" target in several pathologies in which autophagy is critically involved [32] . Moreover, depletion of STK38 suppresses growth of MYC-addicted tumors by decreasing MYC levels and increasing apoptosis, thus we checked the expression of apoptotic markers in HOXD8 expressing cells. As shown in Fig. 7A, HOXD8 expression upregulated the executioner caspases 6 and 7 in HCT116 and DLD-1 cells. Also, expression of HOXD8 increased the apoptotic marker cleaved poly (ADPribose) polymerase (PARP) in both HCT116 and DLD-1 cells. We quantified the western blots using ImageJ analysis (Fig. 7B, 7C and 7D ). Collectively, these findings clearly indicate the tumor suppressor function of HOXD8 via induction of apoptotic pathways in colorectal cancer cells.
STRING database defines the functional interaction partners of HOXD8
As an extension to the previous findings, we used the protein-protein interaction server, STRING, to define HOXD8 functional partners to further dissect its action in CRC. As shown in Supplementary Figure 2 , among top three binding partners, prospero homeobox 1 (prospero homeobox 1) and homeobox D4 (HOXD4) were found to interact with HOXD8.
Discussion
Several HOX genes have been studied and shown to have specific roles in the development and invasion of several types of cancer cells. However, intensive understanding of the underlying molecular mechanisms including their transcriptional target genes, and co-factors or downstream effectors are still lacking. Our group previously demonstrated the significant contribution of several HOX genes to promote epithelial-to-mesenchymal transition (EMT) and invasion of cancer cells. For instance, the homeoproteins ALX1, ALX4 and HOXB13 were found to upregulate expression of the key EMT regulators and abrogate ovarian cancer cells' invasion. [33, 34] . Also, the paired related homeobox 1 (PRRX1) was associated with glioblastoma cell invasion [35] . An improved understanding of the mechanistic insights of these effects may reveal a means to create tailored, precision treatment of several malignancies. Meanwhile, the differential expression pattern of homeobox genes in various carcinomas may provide valuable information for cancer diagnosis of challenging cases of CRC.
In the current report, we investigated the role of HOXD8 in colorectal cancer cells by gain of function strategy given its lower expression in CRC cells. Ectopic expression of HOXD8 suppresses cancer cell proliferation, colony formation and cell invasiveness. Consistently, HOXD8 has previously been linked to differentiation process, whereas retinoic acid-induced differentiation of neuroblastoma upregulates a number of HOX genes including HOXD8 [36] .
Also, individual induction of HOXD8 in neuroblastoma cells is sufficient to downregulate cell cycle-promoting genes and upregulate neuronal differentiation genes. However, depletion of HOXD8 significantly inhibits the retinoic acid-induced differentiation [16] .
Low expression of HOXD8 is reported in several malignancies including pediatric brain tumors [37] and colorectal cancer [1] . In the latter type, HOXD8 expression levels were significantly lower in hepatic metastatic tissues than those in primary tissues proposing a metastasis suppressor function of HOXD8. Given the physiological function of HOXD8 to give the cells positional information in adult, it is thought that loss of HOXD8 may give the cancer cells misinformation to recognize the liver as an orthotopic organ. Hence, disturbance of positional information may render the tumor cells adapted to different micro-environment. Paradoxically, other reports [38, 39] supported the overexpression of HOXD8 in non-small cell lung cancer to promote the cancer phenotype. Based on these findings, HOXD8 plays context-dependent functions in cancers given the nature of HOXD8 as a transcription factor targeting different downstream genes in each type of cancer.
Regarding regulation of HOXD8 in cancer, genome-wide methylation analysis in mantle cell lymphoma [40] and glioblastoma [41] revealed a significant aberrancy in promoter methylation patterns compared with normal cells. Among hypermethylated genes, HOXD8 had an aberrant methylation pattern associated with inverse changes in mRNA levels. In colorectal cancer, several pro-oncogenic miRNAs promote the oncogenic phenotype of colorectal cancer cells. miR196a was reported to exert an oncogenic function in CRC by restricting the expression of HOXA7, HOXB8, HOXC8 and HOXD8 in a dose-dependent and gene-specific manner [17] .
We elucidated the Serine-Threonine Kinase 38, STK38, which is a member of the highly conserved NDR kinase in mammalian cells [42] , and MYC genes to be negatively associated with HOXD8. This negative association is proposed to be responsible for the induction of apoptotic events mediated by HOXD8 in cancer cells. Changes in STK38 expression has been correlated with carcinogenesis. Some reports suggest that overexpression of STK38 is associated with breast ductal carcinoma [43] and melanoma [44] progression. Conversely, in gastric cancer and Bcell lymphoma, STK38 mRNA was downregulated as compared to normal tissues [45, 46] . Hence, the role of STK38 in cancer progression appears to be context dependent. Bisikirska et al. [47] reported that knockdown of STK38 in vivo significantly suppresses B-cell lymphoma in a xenograft mouse model. It is thought that inactivation of STK38 activity reduces MYC protein expression and function, thus suppressing tumorigenesis mediated by MYC oncoprotein and increasing apoptosis. The oncogenic function of MYC is well-known in the etiology of most types of human cancers [48] . Overexpression of MYC oncoprotein elicits autonomous cell proliferation and fueling tumorigenesis [49] . Suppression of MYC activity is considered as a valuable therapeutic tool as inactivation of MYC would likely be associated with cytotoxicity given the physiological function of MYC in normal cells [47] .
Apoptosis or programmed cell death (PCD) is a cellular suicide program required to eliminate superfluous cells for tissue morphogenesis and emerging harmful cells like in case of cancer [50, 51] . Although apoptosis is tightly controlled in normal cells, it is disrupted in cancer to promote infinite cell growth. Also, its regulation on the transcriptional level is less studied and understood [47] . Homeobox genes like HOXD8 are homeodomain transcription factors that have pivotal roles in development by eliciting several developmental programs along the anteriorposterior axis. To this end, homeoproteins transcriptionally regulate cell-type specification, differentiation, proliferation and apoptosis in a highly coordinate manner.
The interplay and regulatory wiring of differentiation and apoptosis are conserved in mammalian cells. For instance, CUT-like homeobox 1 (CUX1) activates the transcription of the proapoptotic gene puma [52] and has emerged as a tumor suppressor via interfering with PI3K
signaling, a pathway known to control apoptosis [53] . Hence, it is very likely that the same regulatory interplay is used by homeobox transcription factors. This is because HOX genes are misregulated in cancer which is often associated with a deteriorated control of apoptotic pathways.
In summary, we propose HOXD8 function to differentially shape tissues and control morphological outputs along the anterior-posterior axis by fine-tuning programmed cell death in healthy organisms. However, lower expression of this gene in CRC disrupts this homeostasis and inhibits apoptosis. Further investigations are required to uncover HOXD8 downstream genes and cofactors essential for target gene regulation and upstream regulators, which are often responsible for HOXD8 deregulation in various types of cancer. Also, the recent knowledge of the homeobox genes in colorectal cancer cancer could not achieve the clinical efficacy of therapeutic targets or biomarkers. Hence, it is required to be fulfilled in the future research.
5.
Figure Legends 
